PAMELA GULLEY: Open Payments
NPI 1598821209 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 3 payments from 3 companies in 2025. Trend: 2023 $240 · 2024 $104 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $83 |
| Alkermes, Inc. | 1 | $81 |
Products named: UZEDY, INGREZZA, LYBALVI.
Industry payments across MO — which companies pay providers there.
